University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier

Simple item page
dc.contributor.authorBentham, Peter
dc.contributor.authorStaff, Roger T.
dc.contributor.authorSchelter, Bjoern O.
dc.contributor.authorShiells, Helen
dc.contributor.authorHarrington, Charles R.
dc.contributor.authorWischik, Claude M.
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Institute for Complex Systems and Mathematical Biology (ICSMB)en
dc.contributor.institutionUniversity of Aberdeen.Physicsen
dc.contributor.institutionUniversity of Aberdeen.Neuroscienceen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.date.accessioned2021-11-16T21:37:00Z
dc.date.available2021-11-16T21:37:00Z
dc.date.issued2021-09-28
dc.descriptionACKNOWLEDGMENTS We thank the patient for permitting publication of the present report. Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/21-0390r1).en
dc.description.statusPeer revieweden
dc.format.extent7
dc.format.extent926810
dc.identifier208679933
dc.identifiere52e5bed-1828-41f4-9eda-fb61d53a8272
dc.identifier85116494713
dc.identifier34366349
dc.identifier.citationBentham, P, Staff, R T, Schelter, B O, Shiells, H, Harrington, C R & Wischik, C M 2021, 'Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier', Journal of Alzheimer's Disease, vol. 83, no. 3, pp. 1017-1023. https://doi.org/10.3233/JAD-210390en
dc.identifier.doi10.3233/JAD-210390
dc.identifier.iss3en
dc.identifier.issn1387-2877
dc.identifier.otherORCID: /0000-0003-2250-3920/work/173415908
dc.identifier.urihttps://hdl.handle.net/2164/17505
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85116494713&partnerID=8YFLogxKen
dc.identifier.vol83en
dc.language.isoeng
dc.relation.ispartofJournal of Alzheimer's Diseaseen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectFrontotemporal dementiaen
dc.subjecthydromethylthionineen
dc.subjectleucomethylthioniniumen
dc.subjectmicrotubule-associated protein tauen
dc.subjectP301Sen
dc.subjectR Medicineen
dc.subjectGeneral Neuroscienceen
dc.subjectClinical Psychologyen
dc.subjectGeriatrics and Gerontologyen
dc.subjectPsychiatry and Mental healthen
dc.subject.lccRen
dc.titleLong-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrieren
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Bentham_et_al_Long_term_Journal_of_alzheimers_disease_vor.pdf
Size:
905.09 KB
Format:
Adobe Portable Document Format
Download

Collections

All research